Atara Biotherapeutics (STU:AT20) Dividend Yield %: 0.00% (As of Jun. 25, 2026)


STU:AT20 Atara Biotherapeutics Inc STU:AT20
31 GF Score
Price €8.80
GF Value €1.30
! 7 Warning Signs
View Full Analysis

What is Atara Biotherapeutics Dividend Yield %?

Atara Biotherapeutics STU:AT20 31 Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus rates STU:AT20 with a GF Score™ of 31/100 and a GF Value™ of €1.30. The stock has 7 warning signs investors should review. Among 151 Biotechnology companies, Atara Biotherapeutics ranks worse than 662250.99% on this metric.

As of today (2026-06-25), the Trailing Annual Dividend Yield of Atara Biotherapeutics is 0.00%.

The historical rank and industry rank for Atara Biotherapeutics's Dividend Yield % or its related term are showing as below:

STU:AT20's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.5
* Ranked among companies with meaningful Dividend Yield % only.

Atara Biotherapeutics's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

As of today (2026-06-25), the Forward Dividend Yield % of Atara Biotherapeutics is 0.00%.

Atara Biotherapeutics's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Atara Biotherapeutics  (STU:AT20) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Atara Biotherapeutics Dividend Yield % Related Terms


Atara Biotherapeutics Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Atara Biotherapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atara Biotherapeutics Dividend Yield % Chart

Atara Biotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Atara Biotherapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:AT20 vs RNTX, IBIO, OSTX: Dividend Yield % Comparison

For the Biotechnology subindustry, Atara Biotherapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atara Biotherapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Dividend Yield % falls into.


STU:AT20
31GF Score
Atara Biotherapeutics Inc STU:AT20
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atara Biotherapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Atara Biotherapeutics (STU:AT20) has a Dividend Yield % of 0.00% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Atara Biotherapeutics and its competitors. According to the industry distribution chart, Atara Biotherapeutics ranks #999999 out of 151 companies in the Biotechnology industry.
Is Atara Biotherapeutics' Dividend Yield % too high?
Atara Biotherapeutics' current Dividend Yield % is 0.00%. Based on the distribution chart, Atara Biotherapeutics ranks #999999 out of 151 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Atara Biotherapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Atara Biotherapeutics' Dividend Yield % compare to RNTX and IBIO?
According to the Biotechnology industry distribution chart, Atara Biotherapeutics ranks #999999 out of 151 companies for Dividend Yield %. This places Atara Biotherapeutics in the lower half of its industry. The industry median Dividend Yield % is 1.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.50, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Atara Biotherapeutics and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atara Biotherapeutics's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atara Biotherapeutics stock overvalued right now?
Atara Biotherapeutics (STU:AT20) has a current Dividend Yield % of 0.00%. The stock's GF Value™ is €1.30, compared to a current price of €8.80 — trading 576.7% above its estimated fair value. The current Dividend Yield % is 0.00%. Atara Biotherapeutics' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Atara Biotherapeutics (STU:AT20), the current Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atara Biotherapeutics (STU:AT20) Overvalued in 2026?

Based on GuruFocus' analysis, Atara Biotherapeutics stock appears to be overvalued. The current stock price of €8.80 is trading 576.7% above its estimated GF Value™ of €1.30.

Key valuation signals for STU:AT20:

  • Dividend Yield %: 0.00%
  • GF Value™: €1.30 vs. price of €8.80 (576.7% above fair value)
  • GF Score™: 31/100 with 7 warning signs

No single metric tells the full story. See the STU:AT20 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Atara Biotherapeutics Business Description

Other Exchanges ATRA:USA0HIY:UKAT20:Germany
Address 1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
31GF Score

Get the complete analysis for STU:AT20

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.80
Price
€1.30
GF Value